ALNYLAM PHARMACEUTICALS, INC.
ALNY$303.65▲ 3.78% 24h
$303.65
-$6.30(-2.03%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
$40.27B
P/E ratio
130.3
EPS (diluted)
$2.33
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$3.71B
Net income
$313.75M
Net margin
8.4%
Gross margin
—
Dividends & financials
ALNYLAM PHARMACEUTICALS, INC. (ALNY) reported revenue of $3.71B and net income of $313.75M, or $2.33 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.
